GlassScriptPhysician profile
Ashley Sorenson
NPI 1245829282
$633.47
in general payments reported to CMS, 2019-2025
17 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $90.14 · 2023: $43.37 · 2024: $87.84 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $139.48 | 2021-2024 | Eliquis |
| Amarin Pharma, INC. | $73.55 | 2021-2022 | |
| Amgen INC. | $63.74 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $52.86 | 2021-2022 | |
| Pfizer INC. | $41.51 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.36 | 2021 | |
| Abiomed | $31.59 | 2024 | Impella |
| Chiesi USA, INC. | $27.29 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $26.79 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $23.90 | 2025 | |
| Genzyme Corporation | $22.69 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.01 | 2025 | |
| United Therapeutics Corporation | $18.39 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $16.21 | 2023 | Inpefa |
| Boston Scientific Corporation | $14.72 | 2025 | Watchman Flx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $14.09 | 2023 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Sorenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.